Geniposide activates the GLP-1R/AKT signaling pathway, which exerts neuroprotective effects against AD and depression by preventing apoptosis and inflammatory processes and promoting neurite outgrowth (Liu W. et al., 2015; Zhao J. et al., 2018). This evidence concerns the gene AKT1 and major depressive disorder.